105 related articles for article (PubMed ID: 3873259)
1. Blockade of a 5-hydroxytryptophan-induced animal model of depression with a potent and selective 5-HT2 receptor antagonist (LY53857).
Hingtgen JN; Fuller RW; Mason NR; Aprison MH
Biol Psychiatry; 1985 Jun; 20(6):592-7. PubMed ID: 3873259
[TBL] [Abstract][Full Text] [Related]
2. Response suppression induced with selective 5-HT agonists can be differentially blocked with LY53857 in an animal model of depression.
Engleman EA; Murphy JM; Zhou FC; Hingtgen JN
Neurochem Res; 1992 May; 17(5):483-8. PubMed ID: 1388251
[TBL] [Abstract][Full Text] [Related]
3. Operant response suppression induced with systemic administration of 5-hydroxytryptophan is centrally mediated.
Engleman EA; Murphy JM; Zhou FC; Aprison MH; Hingtgen JN
Pharmacol Biochem Behav; 1995 Nov; 52(3):525-9. PubMed ID: 8545469
[TBL] [Abstract][Full Text] [Related]
4. LY53857, a selective and potent serotonergic (5-HT2) receptor antagonist, does not lower blood pressure in the spontaneously hypertensive rat.
Cohen ML; Fuller RW; Kurz KD
J Pharmacol Exp Ther; 1983 Nov; 227(2):327-32. PubMed ID: 6313898
[TBL] [Abstract][Full Text] [Related]
5. Postsynaptic serotonergic blockade following chronic antidepressive treatment with trazodone in an animal model of depression.
Hingtgen JN; Hendrie HC; Aprison MH
Pharmacol Biochem Behav; 1984 Mar; 20(3):425-8. PubMed ID: 6608737
[TBL] [Abstract][Full Text] [Related]
6. Response suppression in rats after bilateral microinjection of 5-hydroxytryptophan in lateral hypothalamus.
Hingtgen JN; Shekhar A; DiMicco JA; Aprison MH
Biol Psychiatry; 1988 Apr; 23(7):711-8. PubMed ID: 3259438
[TBL] [Abstract][Full Text] [Related]
7. Evidence for involvement of 5-hydroxytryptamine1 receptors in antidepressant-like drug effects on differential-reinforcement-of-low-rate 72-second behavior.
Marek GJ; Li AA; Seiden LS
J Pharmacol Exp Ther; 1989 Jul; 250(1):60-71. PubMed ID: 2746511
[TBL] [Abstract][Full Text] [Related]
8. Potentiated 5-hydroxytryptophan induced response suppression in rats following chronic reserpine.
Brugge KL; Hingtgen JN; Aprison MH
Pharmacol Biochem Behav; 1987 Feb; 26(2):287-91. PubMed ID: 3495008
[TBL] [Abstract][Full Text] [Related]
9. 1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI) exerts an anorexic action that is blocked by 5-HT2 antagonists in rats.
Schechter LE; Simansky KJ
Psychopharmacology (Berl); 1988; 94(3):342-6. PubMed ID: 3128809
[TBL] [Abstract][Full Text] [Related]
10. Postsynaptic action by four antidepressive drugs in an animal model of depression.
Nagayama H; Hingtgen JN; Aprison MH
Pharmacol Biochem Behav; 1981 Jul; 15(1):125-30. PubMed ID: 6974869
[TBL] [Abstract][Full Text] [Related]
11. Action of chronically administered antidepressants on the serotonergic postsynapse in a model of depression.
Nagayama H; Akiyoshi J; Tobo M
Pharmacol Biochem Behav; 1986 Oct; 25(4):805-11. PubMed ID: 3491369
[TBL] [Abstract][Full Text] [Related]
12. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
Cohen ML; Schenck KW; Kurz KD
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S25-9. PubMed ID: 2459510
[TBL] [Abstract][Full Text] [Related]
13. Involvement of 5-HT1, 5-HT2, and 5-HT3 receptors in the mediation of the prolactin response to serotonin and 5-hydroxytryptophan.
Jørgensen H; Knigge U; Warberg J
Neuroendocrinology; 1992 Mar; 55(3):336-43. PubMed ID: 1386914
[TBL] [Abstract][Full Text] [Related]
14. Effect of chronic treatment with 5-hydroxytryptophan on cortical serotonin receptors in the rat.
Pranzatelli MR
Clin Neuropharmacol; 1988 Jun; 11(3):257-62. PubMed ID: 3261199
[TBL] [Abstract][Full Text] [Related]
15. Involvement of 5-HT2 receptors in the wet-dog shake behaviour induced by 5-hydroxytryptophan in the rat.
Yap CY; Taylor DA
Neuropharmacology; 1983 Jul; 22(7):801-4. PubMed ID: 6604883
[TBL] [Abstract][Full Text] [Related]
16. The head-twitch response to intraperitoneal injection of 5-hydroxytryptophan in the rat: antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, an LSD antagonist.
Colpaert FC; Janssen PA
Neuropharmacology; 1983 Aug; 22(8):993-1000. PubMed ID: 6604885
[TBL] [Abstract][Full Text] [Related]
17. Mediation of ACTH and prolactin responses to 5-HTP by 5-HT2 receptors.
Gartside SE; Cowen PJ
Eur J Pharmacol; 1990 Apr; 179(1-2):103-9. PubMed ID: 2163847
[TBL] [Abstract][Full Text] [Related]
18. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
Darmani NA; Johnson JC
Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
[TBL] [Abstract][Full Text] [Related]
19. The role of the 5-HT2 receptor in the regulation of sexual performance of male rats.
Foreman MM; Hall JL; Love RL
Life Sci; 1989; 45(14):1263-70. PubMed ID: 2811596
[TBL] [Abstract][Full Text] [Related]
20. Behavioral and prolactin responses to 5-hydroxytryptophan in rats treated during development with 5,7-dihydroxytryptamine.
Breese GR; Vogel RA; Kuhn CM; Mailman RB; Mueller RA; Schanberg SM
Brain Res; 1978 Oct; 155(2):263-75. PubMed ID: 308387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
